Residual Effects of Zolpidem Tartrate Extended Release and Eszopiclone Vs Placebo

Summary

Investigation of Psychomotor and Cognitive Residual Effects of Single Oral Doses of Zolpidem Tartrate Extended Release 12.5 mg and Eszopiclone 3 mg Compared to Placebo in Healthy Young Volunteers, Using Flurazepam 30 mg as an External Comparator

Timeline

Start

2006-01

Primary completion

—

Completion

2006-04

Drugs

Indications